Federal Register #DEA-1665

DEA Regulatory Notice: Temporary Scheduling of Four Synthetic Opioids

This notice from the Drug Enforcement Administration (DEA) announces a regulatory action regarding synthetic opioids: - Government Buyer: - Department of Justice, Drug Enforcement Administration (DEA) - Action: Temporary placement of four synthetic opioids into Schedule I of the Controlled Substances Act - 5,6-dichloro brorphine (SR14968) - 5,6-dichloro desmethylchlorphine (SR17018) - N-propionitrile chlorphine (cychlorphine) - Spirochlorphine (R6890) - Includes all isomers, esters, ethers, salts, and salts of isomers, esters, and ethers for each substance - No OEMs, vendors, or commercial products/services are involved - Notable Requirements: - Substances identified in drug seizures and toxicology reports across multiple states - Action taken due to high potential for abuse, lack of accepted medical use, and imminent hazard to public safety - Regulatory controls and sanctions will apply to these substances - No procurement, purchase, or contract is being solicited

Description

The Drug Enforcement Administration (DEA), part of the Department of Justice, intends to temporarily place four synthetic opioids into Schedule I of the Controlled Substances Act. These substances include 5,6-dichloro brorphine, 5,6-dichloro desmethylchlorphine, N-propionitrile chlorphine, and spirochlorphine, along with their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers. The temporary scheduling order will impose regulatory controls and sanctions applicable to Schedule I substances. This action is necessary to avoid an imminent hazard to public safety due to the substances' high potential for abuse and lack of accepted medical use in treatment in the United States.

View original listing